Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sensus Healthcare (SRTS) EPS (Weighted Average and Diluted) (2017 - 2025)

Sensus Healthcare has reported EPS (Weighted Average and Diluted) over the past 9 years, most recently at -$0.19 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 290.0% year-over-year to -$0.19; the TTM value through Dec 2025 reached -$0.47, down 214.63%, while the annual FY2025 figure was -$0.47, 214.63% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.19 at Sensus Healthcare, down from -$0.06 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.97 in Q1 2022 and troughed at -$0.19 in Q4 2025.
  • A 5-year average of $0.08 and a median of $0.04 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 1485.71% in 2022 and later tumbled 290.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.32 in 2021, then tumbled by 43.75% to $0.18 in 2022, then surged by 44.44% to $0.26 in 2023, then plummeted by 61.54% to $0.1 in 2024, then tumbled by 290.0% to -$0.19 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SRTS at -$0.19 in Q4 2025, -$0.06 in Q3 2025, and -$0.06 in Q2 2025.